CSIMarket


Moderna Inc   (MRNA)
Other Ticker:  
 
 

MRNA's Operating Income Growth by Quarter and Year

Moderna Inc 's Operating Income results by quarter and year




MRNA Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -275.04 -3.75 7.78
III Quarter September 3,558.00 -235.12 -2.22 -7.78
II Quarter June 3,062.00 -122.13 -2.78 -3.77
I Quarter March 1,266.00 -130.86 -2.56 -1.22
FY   7,886.00 -763.15 -11.31 -4.99



MRNA Operating Income third quarter 2021 Y/Y Growth Comment
Moderna Inc in the third quarter achieved Operating Income of $ 3,558.00 millions compare to Operating Loss recorded in same quarter a year ago.

Among companies who have reported third quarter results in the Biotechnology & Pharmaceuticals industry only one Company has achieved higher year on year Operating Income results in the third quarter. While Moderna Inc ' s Operating Income no change of % ranks overall at the positon no. 62 in the third quarter.

Explain Operating Income growth


MRNA Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Moderna Inc 's third quarter 2021 Operating Income $ 3,558.00 millions MRNA's Income Statement
Moderna Inc 's third quarter 2020 Operating Income $ -235.12 millions Quarterly MRNA's Income Statement
New: More MRNA's historic Operating Income Growth >>


MRNA Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September 16.2 % - - -
II Quarter June 141.86 % - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #8
Overall #62

Operating Income Y/Y Growth Statistics
High Average Low
502.45 % 300.9 % 99.35 %
(Jun 30 2021)   (Sep 30 2021)
Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #2
Healthcare Sector #8
Overall #62
Operating Income Y/Y Growth Statistics
High Average Low
502.45 % 300.9 % 99.35 %
(Jun 30 2021)   (Sep 30 2021)

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Moderna Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
141.86 % 25.54 % -81.45 %
(Jun 30 2021)  


MRNA's III. Quarter Q/Q Operating Income Comment
Moderna Inc achieved in the III. Quarter 2021 below company average Operating Income jump of 16.2% quarter on quarter, to $ 3,558.00 millions.

III. Quarter 2021 results were contradictory, even if beneath the ordinary rise of 25.54 %, yet it demonstrates absolute recovery measured to the % in the III. Quarter a year ago.

Within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher Operating Income quarter on quarter growth. While Moderna Inc 's Operating Income growth quarter on quarter, overall rank is 464.


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #37
Overall #464
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #37
Overall #464
Operating Income Q/Q Growth Statistics
High Average Low
141.86 % 25.54 % -81.45 %
(Jun 30 2021)  


MRNA's III. Quarter Q/Q Operating Income Comment
Moderna Inc achieved in the III. Quarter 2021 below company average Operating Income jump of 16.2% quarter on quarter, to $ 3,558.00 millions.

Albeit the III. Quarter 2021 results were lower than the regular , it was still good sign, as the current expension, outshines the % Operating Income rise in the III. Quarter 2020

Within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher Operating Income quarter on quarter growth. While Moderna Inc 's Operating Income growth quarter on quarter, overall rank is 464.


Moderna Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Operating Income 12 Months Ending $ 7,610.96 $ 3,817.85 $ 633.72 $ -763.14 $ -491.86
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) 99.35 % 502.45 % - - -
Seq. Operating Income Growth (TTM) Overall Ranking # 62 # 41 # 0 # 0 # 0




Cumulative Operating Income growth Comment
In the Sep 30 2021 period, Moderna Inc had cumulative twelve months Operating Income of $ 7,611 millions compare to Operating Loss of $ -492 millions a year ago.

Moderna Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
502.45 %
300.9 %
99.35 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 8
S&P 500 # 62
Cumulative Operating Income growth Comment
In the Sep 30 2021 period, Moderna Inc had cumulative twelve months Operating Income of $ 7,611 millions compare to Operating Loss of $ -492 millions a year ago.

Moderna Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
502.45 %
300.9 %
99.35 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 8
S&P 500 # 62




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
MRNA's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for MRNA's Competitors
Operating Income Growth for Moderna Inc 's Suppliers
Operating Income Growth for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Dividend Payout Ratio
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons



Companies with similar Operating Income jump for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2021
Regional Health Properties Inc -0.32%$ -0.317 millions
Abiomed Inc -1.47%$ -1.467 millions
Integra Lifesciences Holdings Corp-1.92%$ -1.917 millions
Semler Scientific inc -5.44%$ -5.437 millions
Phibro Animal Health Corp-6.86%$ -6.859 millions
Quidel Corporation-8.48%$ -8.481 millions
Conmed Corporation-9.09%$ -9.091 millions
Quest Diagnostics Inc-9.19%$ -9.192 millions
Lemaitre Vascular Inc-9.43%$ -9.433 millions
Universal Health Services Inc -9.97%$ -9.970 millions
Amedisys Inc-10.33%$ -10.331 millions
Meridian Bioscience Inc -10.40%$ -10.397 millions
Fourth Wave Energy Inc -10.53%$ -10.525 millions
Fitlife Brands Inc -13.80%$ -13.795 millions
Fonar Corporation-13.94%$ -13.941 millions
Essa Pharma inc -14.07%$ -14.072 millions
Pro dex Inc -14.91%$ -14.913 millions
U S Physical Therapy Inc-15.06%$ -15.064 millions
Owens and Minor Inc -16.78%$ -16.780 millions
Protokinetix Incorporated-16.92%$ -16.917 millions
Steris Plc-17.53%$ -17.528 millions
Electromed Inc -18.85%$ -18.852 millions
Biodelivery Sciences International Inc -20.22%$ -20.222 millions
Alr Technologies Inc -21.93%$ -21.929 millions
Petmed Express Inc-22.77%$ -22.768 millions
Retractable Technologies inc -23.02%$ -23.019 millions
Vyne Therapeutics Inc -24.33%$ -24.328 millions
Laboratory Corporation Of America Holdings-26.76%$ -26.760 millions
Biogen Inc -26.91%$ -26.915 millions
Viemed Healthcare Inc -27.75%$ -27.748 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CHWAU's Profile

Stock Price

CHWAU's Financials

Business Description

Fundamentals

Charts & Quotes

CHWAU's News

Suppliers

CHWAU's Competitors

Customers & Markets

Economic Indicators

CHWAU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071